QPPV.COM KNOWLEDGE ASSESSMENT

EudraVigilance Signal Detection

Test your understanding of the concepts covered by EudraVigilance Signal Detection.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which factor can produce an apparent disproportionality without necessarily indicating a causal product-event relationship?

Stimulated reporting following increased public attention A documented positive dechallenge A consistent temporal relationship in several high-quality cases A biologically plausible mechanism supported by external evidence

Question 2 of 10 A spontaneous reporting analysis estimates 0.5 reports per 1,000 patient-years. How should this result be described?

As the confirmed incidence rate of syncope As a spontaneous reporting rate that may provide context but is not an incidence estimate As proof that the event is caused by the product As an estimate that can be directly compared with clinical trial incidence without qualification

Question 3 of 10 Which feature of an EVDAS screening archive most directly supports reproducibility?

A file name without any additional information The export date and time, user, query configuration, statistical method, thresholds and filters A summary of the product's commercial strategy A list of unrelated safety topics reviewed during the year

Question 4 of 10 Which governance practice best supports appropriate QPPV oversight?

Limit the QPPV's involvement to signing the final assessment Provide regular reporting on signal activities and ensure visibility of significant signals and decisions Allow the operational signal lead to make all decisions without escalation Retain governance minutes only when regulatory action is taken

Question 5 of 10 A company closes an SDR because all reports are incomplete, but the event is serious and there is a possible temporal pattern. What would be the most appropriate process response?

Accept the closure without documentation because incomplete cases cannot be relevant Document the limitations and rationale, consider monitoring or information gathering, and ensure the decision is consistent with the SOP Automatically classify the SDR as a confirmed signal Remove the cases from the EudraVigilance analysis

Question 6 of 10 What is the main inspection risk when an MAH applies statistical thresholds inconsistently across products without documented justification?

The database will automatically delete prior reports The process may lack reproducibility, transparency and a defensible basis for prioritisation decisions The clinical reviewers will be unable to access literature The QPPV will no longer have regulatory accountability

Question 7 of 10 Which evidence would be most useful in assessing whether a potential syncope signal is confounded by concomitant treatment?

The file name of the EVDAS export Analysis of concomitant medications, dose changes and relevant comorbidities across the case series The number of governance meetings held during the year The existence of a general pharmacovigilance training record

Question 8 of 10 What is the main reason for using complementary analyses such as time-to-onset, subgroup disproportionality and time-trend review?

To eliminate the need for individual case review To improve the stability and interpretability of potential signals by examining different dimensions of the data To ensure every SDR becomes a validated signal To convert spontaneous reporting rates into incidence rates

Question 9 of 10 Which element is most important when assigning priority to an SDR?

Statistical strength alone A combination of statistical findings, seriousness, novelty, plausibility and potential public health impact The seniority of the person who first noticed the SDR Whether the event appears in a competitor's product information

Question 10 of 10 Why might an EBGM result be less prominent than a PRR result when the number of reports is small?

EBGM excludes serious cases from its calculation EBGM uses shrinkage, which pulls unstable low-count estimates toward the null EBGM measures only exposure-adjusted incidence EBGM cannot be calculated for adverse events

EudraVigilance Signal Detection

Cookie Settings